Maetzold Derek J's Form 4 filing
Castle Biosciences Inc (CSTL) · filed May 16, 2024
- Accession no.
- 0001447362-24-000070
- Filed
- May 16, 2024
- Trade date
- May 14, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 14 non-derivative transactions. Open-market sales total $153.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maetzold Derek JCIK 0001239501 | Director, Officer (Pres. & Chief Exec. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 14, 2024 | Common Stock | SSaleDisposed | −2,085 | $24.17F2 | −$50,394.45 | 60,544 | Direct | |
| May 14, 2024 | Common Stock | SSaleDisposed | −1,067 | $24.17F2 | −$25,789.39 | 83,839 | Indirect | |
| May 14, 2024 | Common Stock | SSaleDisposed | −1,067 | $24.17F2 | −$25,789.39 | 72,736 | Indirect | |
| May 14, 2024 | Common Stock | SSaleDisposed | −340 | $24.17F2 | −$8,217.8 | 8,959 | Indirect | |
| May 14, 2024 | Common Stock | SSaleDisposed | −340 | $24.17F2 | −$8,217.8 | 8,957 | Indirect | |
| May 14, 2024 | Common Stock | SSaleDisposed | −340 | $24.17F2 | −$8,217.8 | 8,957 | Indirect | |
| May 14, 2024 | Common Stock | SSaleDisposed | −340 | $24.17F2 | −$8,217.8 | 8,957 | Indirect | |
| May 14, 2024 | Common Stock | SSaleDisposed | −283 | $24.95F9 | −$7,060.85 | 60,261 | Direct | |
| May 14, 2024 | Common Stock | SSaleDisposed | −145 | $24.95F9 | −$3,617.75 | 83,694 | Indirect | |
| May 14, 2024 | Common Stock | SSaleDisposed | −145 | $24.95F9 | −$3,617.75 | 72,591 | Indirect | |
| May 14, 2024 | Common Stock | SSaleDisposed | −46 | $24.95F9 | −$1,147.7 | 8,913 | Indirect | |
| May 14, 2024 | Common Stock | SSaleDisposed | −46 | $24.95F9 | −$1,147.7 | 8,911 | Indirect | |
| May 14, 2024 | Common Stock | SSaleDisposed | −46 | $24.95F9 | −$1,147.7 | 8,911 | Indirect | |
| May 14, 2024 | Common Stock | SSaleDisposed | −46 | $24.95F9 | −$1,147.7 | 8,911 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $23.88 to $24.51, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $24.92 to $25.00, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.